Me2on Balance Sheet Health
Financial Health criteria checks 6/6
Me2on has a total shareholder equity of ₩230.7B and total debt of ₩19.2B, which brings its debt-to-equity ratio to 8.3%. Its total assets and total liabilities are ₩271.3B and ₩40.5B respectively. Me2on's EBIT is ₩14.7B making its interest coverage ratio -4.5. It has cash and short-term investments of ₩77.4B.
Key information
8.3%
Debt to equity ratio
₩19.22b
Debt
Interest coverage ratio | -4.5x |
Cash | ₩77.37b |
Equity | ₩230.75b |
Total liabilities | ₩40.55b |
Total assets | ₩271.29b |
Recent financial health updates
Recent updates
Me2on's (KOSDAQ:201490) Returns On Capital Not Reflecting Well On The Business
Nov 12Subdued Growth No Barrier To Me2on Co., Ltd.'s (KOSDAQ:201490) Price
Sep 10Calculating The Fair Value Of Me2on Co., Ltd. (KOSDAQ:201490)
Mar 29Can Me2on (KOSDAQ:201490) Prolong Its Impressive Returns?
Mar 01Me2on (KOSDAQ:201490) Seems To Use Debt Rather Sparingly
Feb 08Me2on Co., Ltd.'s (KOSDAQ:201490) Stock Been Rising: Are Strong Financials Guiding The Market?
Jan 20If You Had Bought Me2on's (KOSDAQ:201490) Shares Three Years Ago You Would Be Down 23%
Jan 01Here's Why We Think Me2on's (KOSDAQ:201490) Statutory Earnings Might Be Conservative
Dec 14Does Me2on (KOSDAQ:201490) Deserve A Spot On Your Watchlist?
Nov 25Financial Position Analysis
Short Term Liabilities: A201490's short term assets (₩92.9B) exceed its short term liabilities (₩33.0B).
Long Term Liabilities: A201490's short term assets (₩92.9B) exceed its long term liabilities (₩7.5B).
Debt to Equity History and Analysis
Debt Level: A201490 has more cash than its total debt.
Reducing Debt: A201490's debt to equity ratio has reduced from 54.5% to 8.3% over the past 5 years.
Debt Coverage: A201490's debt is well covered by operating cash flow (124.6%).
Interest Coverage: A201490 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/08 04:53 |
End of Day Share Price | 2025/01/08 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Me2on Co., Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jongsun Park | Eugene Investment & Securities Co Ltd. |
ARam Kim | Shinhan Investment Corp. |
Dongguen Kang | Yuanta Securities Korea Co., Ltd. |